drug
mechlorethamine hydrochloride
Marketedupdated 4mo agoby Helsinn Therapeutics (US) Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying mechlorethamine hydrochloride
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 8, 2029
~2.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (6)
- Jul 8, 2029method-of-use (U-1427)US 78720502.9y
- Mar 7, 2026formulationUS 7838564
- Mar 7, 2026formulationUS 8450375
- Mar 7, 2026formulationUS 8501818
- Mar 7, 2026method-of-use (U-1427)US 8501819
- Mar 7, 2026formulationUS 9382191
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that